Value proposition

Improving life by making rapid results accessible to all. Lateral flow test development, manufacture & commercialisation

We are lateral flow CDMO experts based in the UK supporting global customers bring their assays to market, from proof of concept, through optimisation and scale up to routine manufacture, along with full-service regulatory consultancy support. Get in touch: email info@abingdonhealth.com today.

We believe that by developing the high quality, effective lateral flow rapid tests combined with our manufacturing experience and scale, we can provide the means to accelerate access to rapid testing. This means faster diagnosis and screening in the field, accelerating the ability of decision makers to deploy a more rapid response to results.

We are committed and honest in all that we do. We value the quality and contribution of all, priding ourselves on building long-lasting and trusting partnerships – because by working transparently with customers, partners and colleagues, we are better together. With an exceptional pedigree in developing and manufacturing rapid tests Abingdon Health are expert in responding to our customers varied needs with specific and customisable solutions.

Our mission: To improve life by making rapid results accessible to all. By providing the best lateral flow rapid test solutions, we believe we can support the increase in access to diagnostics across many industries and locations throughout the world. Faster access to results allows for rapid decision making and solutions. This ability has a significant role to play in improving life in so many ways.

Medical Diagnostics, Infectious Diseases, Point of Care Testing, Monoclonal Antibodies, Rapid Tests, Animal Health, Agri-Food, Lateral Flow Manufacturing, Lateral Flow Assay Development, Assay Reader Systems, Smartphone lateral flow reader, mHealth, COVID-19 rapid tests, and IgG neutralising antibody tests